Inflamed journeys: Understanding ulcerative colitis

---

Review Article

Author Details : Pradneshwari M. Joshi*, Ganesh D. Barkade, Ramesh L. Sawant

Volume : 12, Issue : 2, Year : 2024

Article Page : 84-94

https://doi.org/10.18231/j.jpbs.2024.014

Suggest article by email

Get Permission

---

Abstract

Ulcerative Colitis is a kind of IBD (Inflammatory Bowel Disease). Recurrent episodes of gastrointestinal tract inflammation brought on by an aberrant immune response to gut microbiota is what defines IBD. India has the highest reported incidence of IBD (931 cases per 100,000 people) and UC (5.41 cases per 100,000 people) among the world's developing nations. It's interesting to note that whereas UC is more common in Northern India, CD is more common in Southern India. In a few years, India may have the highest overall burden of IBD due to its large population. Globally, the burden of disease will keep increasing because mortality is often low.The present study reveals historical background, epidemiology, and pathophysiology of Ulcerative Colitis, while also drawing comparisons between modern treatment modalities and traditional systems like Ayurveda. Ongoing research is focused on refining treatment strategies, with a tailored approach to enhance patient outcomes, minimize recurrence, and improve the quality of life for individuals dealing with Ulcerative Colitis.

Keywords: Allopathy, Ayurveda, Current treatment, Immunity, Inflammatory bowel disease (IBD), Ulcerative Colitis

How to cite : Joshi P M, Barkade G D, Sawant R L, Inflamed journeys: Understanding ulcerative colitis. J Pharm Biol Sci 2024;12(2):84-94

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.